Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyo Yamaguchi

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Antimicrobial Chemotherapy|December 22, 2010
Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infectionKatsuhisa Uchida, Kosuke Shimogawara, Hideyo Yamaguchi
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|June 30, 2004
Potential usefulness of bovine lactoferrrin for adjunctive immunotherapy for mucosal Candida infectionsHideyo Yamaguchi, Shigeru Abe, Natsuko Takakura
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 15, 2004
In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agentKatsuhisa Uchida, Yayoi Nishiyama, Hideyo Yamaguchi
Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology|August 31, 2006
[Studies on the correlation of the method currently used by the Japanese Society for Medical Mycology and its modified method with the NCCLS M27-A2 microdilution method for azole susceptibility testing of Candida species]Katsuhisa Uchida, Yayoi Nishiyama, Hideyo Yamaguchi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 13, 2019
[Drug properties of fosravuconazole L-lysine ethanolate (NAILIN<sup>®</sup> Capsules 100 mg), a new oral azole therapeutic for onychomycosis: an analysis based on non-clinical and clinical trial data]Makoto Nakano, Yuto Aoki, Hideyo Yamaguchi
European Journal of Dermatology : EJD|March 2, 2002
Pityriasis versicolor rubraManubu Maeda, Koi Chi Makimura, Hideyo Yamaguchi
Journal of Medical Microbiology|March 9, 2000
In-situ detection of Aspergillus fumigatusRyo Hanazawa, Somay Yamagata Murayama, Hideyo Yamaguchi
International Journal of Antimicrobial Agents|March 15, 2003
In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia speciesKatsuhisa Uchida, Yayoi Nishiyama, Takashi Tanaka, et al.
Microbiology and Immunology|September 12, 2002
KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigsYoshiyuki Tatsum, Mamoru Yokoo, Tadashi Arika, et al.
Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology|August 31, 2006
A one-enzyme PCR-RFLP assay for identification of six medically important Candida speciesHossein Mirhendi, Koichi Makimura, Mohamadreza Khoramizadeh, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Antimicrobial Chemotherapy|December 22, 2010
Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infectionKatsuhisa Uchida, Kosuke Shimogawara, Hideyo Yamaguchi
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|June 30, 2004
Potential usefulness of bovine lactoferrrin for adjunctive immunotherapy for mucosal Candida infectionsHideyo Yamaguchi, Shigeru Abe, Natsuko Takakura
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 15, 2004
In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agentKatsuhisa Uchida, Yayoi Nishiyama, Hideyo Yamaguchi
Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology|August 31, 2006
[Studies on the correlation of the method currently used by the Japanese Society for Medical Mycology and its modified method with the NCCLS M27-A2 microdilution method for azole susceptibility testing of Candida species]Katsuhisa Uchida, Yayoi Nishiyama, Hideyo Yamaguchi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 13, 2019
[Drug properties of fosravuconazole L-lysine ethanolate (NAILIN<sup>®</sup> Capsules 100 mg), a new oral azole therapeutic for onychomycosis: an analysis based on non-clinical and clinical trial data]Makoto Nakano, Yuto Aoki, Hideyo Yamaguchi
European Journal of Dermatology : EJD|March 2, 2002
Pityriasis versicolor rubraManubu Maeda, Koi Chi Makimura, Hideyo Yamaguchi
Journal of Medical Microbiology|March 9, 2000
In-situ detection of Aspergillus fumigatusRyo Hanazawa, Somay Yamagata Murayama, Hideyo Yamaguchi
International Journal of Antimicrobial Agents|March 15, 2003
In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia speciesKatsuhisa Uchida, Yayoi Nishiyama, Takashi Tanaka, et al.
Microbiology and Immunology|September 12, 2002
KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigsYoshiyuki Tatsum, Mamoru Yokoo, Tadashi Arika, et al.
Nihon Ishinkin Gakkai Zasshi = Japanese Journal of Medical Mycology|August 31, 2006
A one-enzyme PCR-RFLP assay for identification of six medically important Candida speciesHossein Mirhendi, Koichi Makimura, Mohamadreza Khoramizadeh, et al.
Pageof 12